Peter Maccallum Cancer Centre, Australia
Clinical trials sponsored by Peter Maccallum Cancer Centre, Australia, explained in plain language.
-
Could early antibiotic stop be safe for high-risk blood cancer patients?
Disease control Recruiting nowThis study looks at whether it is safe to stop antibiotics early in adults with high-risk blood cancers or those who have had stem cell transplants or CAR T-cell therapy. Participants will be randomly assigned to stop antibiotics once their fever goes away or continue until their…
Phase: NA • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Fungal spy scan: new PET tracks hidden infections
Diagnosis Recruiting nowThis study tests a new type of PET scan that uses a radioactive fungal component (siderophore) to light up areas of invasive Aspergillus infection in the body. Ten adults with suspected or confirmed fungal infections will receive the scan to see if it can accurately locate the in…
Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Diagnosis
Last updated May 22, 2026 13:55 UTC
-
Cholesterol drug may ease swallowing trouble in cancer survivors
Symptom relief Recruiting nowThis study tests whether pravastatin, a medicine used for cholesterol, can improve swallowing in people who have had radiation for head and neck cancer. About 48 adults who have had swallowing problems for at least 2 years after treatment will take pravastatin daily for 12 months…
Phase: PHASE2 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Symptom relief
Last updated May 20, 2026 11:54 UTC
-
Light therapy may ease painful mouth sores for oral cancer patients
Symptom relief Recruiting nowThis study tests if a special light treatment, called photobiomodulation, can reduce the severity and frequency of painful mouth sores caused by radiation therapy in oral cancer patients. About 30 adults who have had surgery for oral cancer and are scheduled for radiation will re…
Phase: NA • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC
-
New study investigates Immunotherapy's impact on reproductive health
Knowledge-focused Recruiting nowThis study looks at how immune checkpoint inhibitor (ICI) treatment for melanoma affects reproductive organs and sex hormones. Researchers will collect blood samples and questionnaires from 80 participants during their regular treatment visits. Men will also provide semen samples…
Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Knowledge-focused
Last updated May 26, 2026 07:53 UTC